Trial of amifostine in autologous stem cell transplant [5]

Bone Marrow Transplantation

Volumn 37, Issue 1, 2006, Pages 117-118

  Sastry, P ^a   Bhagwat, R ^a   Biswas, G ^a   Khadwal, A ^a   Narayanan, P ^a   Bakshi, A ^a   Parikh, P ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMIFOSTINE; ANTIBIOTIC AGENT; CARMUSTINE; CREATININE; CYTARABINE; ETOPOSIDE; GROWTH FACTOR; MELPHALAN; NARCOTIC ANALGESIC AGENT;

ADULT; ALBUMIN BLOOD LEVEL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TOXICITY; BRADYCARDIA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG FATALITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; GLOMERULUS FILTRATION RATE; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LETTER; LIVER VENOOCCLUSIVE DISEASE; LUNG FUNCTION TEST; LUNG TOXICITY; MALE; MOUTH INFLAMMATION; MUCOSA INFLAMMATION; MYELOMA; PARENTERAL NUTRITION; PRIORITY JOURNAL; SEPSIS; VOMITING;

ADOLESCENT; ADULT; AMIFOSTINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CHILD; CYTARABINE; FEMALE; GRAFT SURVIVAL; HODGKIN DISEASE; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PODOPHYLLOTOXIN; RADIATION-PROTECTIVE AGENTS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 31344441705     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705204     Document Type: Letter

References (4)

1. Spencer A, Horvath N, Gibson J, Prince HM, Hermann R, Bashford J et al. Prospective randomized trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphelan conditioned autologous stem cell transplantation. Bone Marrow Transplant 2005; 35: 971-977.
2. Thieblemont C, Dumontet C, Saad H, Roche N, Bouafia F, Arnaud P et al. Amifostine reduces mucosal damage after high dose melphelan conditioning and autologous peripheral blood progenitor cell transplantation in patients with multiple myeloma. Bone Marrow transplant 2002; 30: 769-775.
3. Philips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J et al. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphelan: A phase 1 study. Biol Blood Marrow Transplant 2004; 10: 473-483.
4. Capelli D, Santini G, De Souza C, Poloni A, Marino G, Montanari M et al. Amifostine can reduce mucosal damage after high-dose melphelan conditioning for peripheral blood progenitor cell autotransplant: A retrospective study. Br J Hematol 2000; 110: 300-307.